Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis

被引:0
作者
Junjie Zhao
Weidong Xu
Zhensheng Zhang
Ruixiang Song
Shuxiong Zeng
Yinghao Sun
Chuanliang Xu
机构
[1] The Second Military Medical University,Department of Urology, Changhai Hospital
来源
International Urology and Nephrology | 2015年 / 47卷
关键词
Bladder cancer; Human epidermal growth factor receptor 2; Meta-analysis; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:87 / 94
页数:7
相关论文
共 268 条
[1]  
Siegel R(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
[2]  
Ma J(2009)Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer J Urol 182 2625-2630
[3]  
Zou Z(2006)Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure World J Urol 24 296-304
[4]  
Jemal A(2006)Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer N Engl J Med 354 809-820
[5]  
Cho KS(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697
[6]  
Seo HK(2014)Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma Int J Colorectal Dis 29 663-671
[7]  
Joung JY(2012)EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis Hum Pathol 43 921-931
[8]  
Park WS(1990)Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer Mol Carcinog 3 254-257
[9]  
Ro JY(2007)Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 16-605
[10]  
Han KS(2010)Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 25 603-1343